Top development trends in the Russian pharmaceutical industry 2016

Reducing costs and introducing new medicines

Deloitte CIS Research Centre

Deloitte would like to thank you for your participation in the May 2016 survey, which was part of the research project entitled “Development trends and practical aspects of the Russian pharmaceutical industry 2016.” Your expert opinion helped us perform a comprehensive review of the Russian pharmaceutical industry and analyse the sentiment and expectations of the market participants with respect to the Russian pharmaceutical market’s growth as well as their own.

Over 70 respondents representing 50 Russian and foreign manufacturers of original medicines and generics in Russia and abroad, and pharmaceutical distributors participated in the 2016 survey.

Key issues:

Statistical survey of key Russian pharmaceutical industry indicators

Russian pharmaceutical industry: current situation and forecast

Russian pharmaceutical companies: current situation and forecast

List of main issues facing the Russian pharmaceutical industry

Russian pharmaceutical business development strategies

Cost optimisation options

Trading policy in the Russian pharmaceutical market

Government measures aimed at reducing the share of imported medicines

Key government regulation areas to be improved

This survey has been conducted annually since 2013 and forms the basis for a comprehensive study on the Russian pharmaceutical industry. We would be very grateful if you would consider participating in our next survey as well.

Key contacts

Partner, Tax&Legal

Oleg joined Deloitte in 2003. He has 20 years of tax consulting experience and currently heads the Indirect Tax & Customs group, the Life Sciences and Healthcare Industry group and the Chinese Service... More

Research Center Leader

Before joining Deloitte, Lora worked for the Russian Public Opinion Research Center (WCIOM), leading research projects. Lora has a candidate of science degree in economics. She conducts full-cycle bus... More

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see www.deloitte.com/about to learn more about our global network of member firms.